Women experiencing postpartum haemorrhages, which affect 5-15% of new mothers, may soon have more treatment options with the addition of the JADA device to Australia’s therapeutic goods register. This device uses low-level vacuum to induce uterine contractions, potentially improving outcomes for those facing this serious condition that can lead to significant physical and psychological impacts.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
